Source comparison
Wolverine Stack vs BPC-157 + TB-500: Full Comparison
Peptide composition BPC-157 (2mg), TB-500 (2mg), KPV (500mcg) per vial BPC-157 and TB-500 sourced independently; KPV optional Wolverine adds KPV. Not standard in most tissue repair protocols Dose flexibility Fixed 4:4:1 ratio; no independent titration Each pep
This comparison does not assign a generated winner or score.
- Peptide composition
- BPC-157 (2mg), TB-500 (2mg), KPV (500mcg) per vial
- BPC-157 and TB-500 sourced independently; KPV optional
- Wolverine adds KPV. Not standard in most tissue repair protocols
- Dose flexibility
- Fixed 4:4:1 ratio; no independent titration
- Each peptide dosed independently per protocol
- Separate peptides required for dose-response studies
- Injection frequency
- Daily (dictated by BPC-157's short half-life)
- BPC-157 daily; TB-500 twice weekly; KPV as needed
- Wolverine over-delivers TB-500 relative to its pharmacokinetics
- Reconstitution logistics
- Single vial reconstitution
- Three separate vials if using all three peptides
- Wolverine reduces prep time but eliminates dose control
- Cost per research cycle
- $120–$180 per vial (30-day supply at 1mg/day blended dose)
- $60–$90 BPC-157 + $80–$120 TB-500 + $40–$70 KPV (if used) = $180–$280
- Wolverine is cost-neutral if you need all three; more expensive if you don't need KPV
- Mechanism overlap
- BPC-157 (angiogenesis), TB-500 (cell migration), KPV (inflammation modulation)
- BPC-157 and TB-500 only. Inflammation managed by endogenous response
- KPV addition may interfere with acute inflammatory signalling in early injury phases